SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-24-265605
Filing Date
2024-11-26
Accepted
2024-11-26 07:00:56
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC TO-C d901640dsctoc.htm SC TO-C 21068
2 EX-99.1 d901640dex991.htm EX-99.1 49253
3 EX-99.2 d901640dex992.htm EX-99.2 142335
4 GRAPHIC g901640g1126071720957.jpg GRAPHIC 2000
5 GRAPHIC g901640g1126072002659.jpg GRAPHIC 2009
  Complete submission text file 0001193125-24-265605.txt   220214
Mailing Address 1 DNA WAY, MS #24, SOUTH SAN FRANCISCO CA 94080
Business Address C/O THE CORPORATION TRUST, 1209 ORANGE STREET, WILMINGTON, DE 19801 650 225-7893
ROCHE HOLDINGS INC (Filed by) CIK: 0000904566 (see all company filings)

IRS No.: 510304944 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 0000

Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Subject) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-91606 | Film No.: 241498133
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)